Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ADPT compared with DNA: revenue, margins and what each company keeps, and the suppliers and customers both name
ADPT
Adaptive Biotechnologies Corp
Change
Mkt cap
Revenue
Revenue
DNA
Ginkgo Bioworks Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ADPT
Adaptive Biotechnologies Corp
vs
DNA
Ginkgo Bioworks Holdings, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ADPT: latest quarter is a loss; flow not drawable. DNA: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ADPT
6
PFE
Pfizer
customer
ILMN
Illumina
supplier
—
Fred Hutchinson Cancer Research Center
unlisted
supplier
—
Genentech
unlisted
customer
2 more · ADPT chain
›
Shared
0
No shared counterparties.
Only DNA
6
TWST
Twist
supplier
—
Google Cloud
unlisted
supplier
—
Virica Biotech
unlisted
supplier
—
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
BiomEdit
unlisted
customer
2 more · DNA chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ADPT, solid
DNA, dashed
ADPT
Adaptive Biotechnologies Corp
Change
26.62
▼
−5.51%
· post 26.60
Mkt cap
$4.3B
Revenue
$72M
Q2 FY26
Revenue
$277M
FY25
DNA
Ginkgo Bioworks Holdings, Inc.
Change
11.25
▼
−11.68%
· post 11.12
Closed
Oct 30 '26
Mkt cap
$754.9M
Revenue
$20M
Q2 FY26
Revenue
$150M
FY25
vs
Compare
Closed
Oct 30 '26
ADPT
Adaptive Biotechnologies Corp
vs
DNA
Ginkgo Bioworks Holdings, Inc.
26.62
▼
−5.51%
post 26.60
Price
11.25
▼
−11.68%
post 11.12
$4.3B
Mkt cap
$754.9M
Q2 FY26
$72M
Revenue
$20M
Q2 FY26
FY25
$277M
Revenue
$150M
FY25
Change
Change
ADPT
26.62
▼
−5.51%
vs
DNA
11.25
▼
−11.68%
Closed
Oct 30 '26